[{"arm_notes": "", "treatment_id": null, "treatment_name": "Ten patients with COVID-19 will receive an intravenous infusion of three doses of 500.000 cells/kg of umbilical cord mesechymal cells and five patients will receive a placebo (saline; albumin and ACD infusion). Conventional treatment will be performed together with the infusion of cells; during the study period. It will be performed clinical; laboratory; and medical diagnosis imaging evaluation. Patient follow-up will be for four months after the first infusion of cells;E04.936", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1334, "treatment_name": "Umbilical cord mesenchymal stem cells", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Ten patients with COVID-19 will receive an intravenous infusion of three doses of 500.000 cells/kg of umbilical cord mesechymal cells and five patients will receive a placebo (saline; albumin and ACD infusion). Conventional treatment will be performed together with the infusion of cells; during the study period. It will be performed clinical; laboratory; and medical diagnosis imaging evaluation. Patient follow-up will be for four months after the first infusion of cells;Biological/vaccine;E04.936", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Ten patients with COVID-19 will receive an intravenous infusion of three doses of 500.000 cells/kg of umbilical cord mesechymal cells and five patients will receive a placebo (saline; albumin and ACD infusion). Conventional treatment will be performed together with the infusion of cells; during the study period. It will be performed clinical; laboratory; and medical diagnosis imaging evaluation. Patient follow-up will be for four months after the first infusion of cells;Biological/vaccine;Transplantation", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]